Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

Martha Sazon, ranked No. 38 on the Fortune Most Powerful Women Asia list this year, joined Mynt as president and CEO in June ...

Naqi Logix founder Dave Segal has invented a device that lets anyone control a computer with their head—no brain implant required.

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

Mumbai: A retired GlaxoSmithKline (GSK) employee, Ashok Shetty, on Monday reported a home burglary involving the theft of ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...